<DOC>
	<DOCNO>NCT01963949</DOCNO>
	<brief_summary>To collect tumor tissue patient liver mass suspicious primary liver cancer . The research biopsy use identify biomarkers future study .</brief_summary>
	<brief_title>Prospective , Observational Study Biomarkers Liver Cancer - Identification Actionable Events</brief_title>
	<detailed_description>In study patient refer Department Radiology image-guided ( either CT ultrasound ) core needle biopsy liver mass suspicious primary liver cancer part clinical care . A write informed consent obtain clinical biopsy per standard protocol . Additional core biopsy liver mass perform research purpose time clinical care biopsy . The additional research biopsy mandatory subject separate write informed consent , obtain prior clinical biopsy .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Liver mass suspicious primary liver cancer diagnostic liver biopsy plan part clinical care 2 . Age ≥ 18 year . 3 . ECOG performance status 02 4 . Adequate organ marrow function define : INR ≤ 1.5 platelet ≥ 70,000/mcl 5 . Ability understand willingness sign write informed consent 6 . Target liver mass subcapsular nature determine participate biopsy team 7 . Child Pugh Turcotte score A B 1 . Previous treatment HCC 2 . Any contraindication clinicalcare liver biopsy , include anticoagulation therapy discontinue prior biopsy large volume ascites</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>